Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: Clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay [1]

British Journal of Haematology

Volumn 139, Issue 1, 2007, Pages 159-161

  Arber, Caroline ^a   Bertrand, Gerald ^b   Halter, Jörg ^a   Boehlen, Françoise ^c   Kaplan, Cécile ^b   Gratwohl, Alois ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Alloimmunization; Human platelet antigen; Platelet antibodies; Transfusion refractoriness; Transplantation

Indexed keywords

ALLOANTIBODY; CYTARABINE; HLA ANTIBODY; HLA ANTIGEN; HPA 5A ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNIZATION; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; FEMALE; GENOTYPE; HUMAN; LETTER; MYELOID LEUKEMIA; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ACUTE DISEASE; ANTIGENS, HUMAN PLATELET; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; ISOANTIBODIES; LEUKEMIA, MYELOID; MIDDLE AGED; PLATELET TRANSFUSION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE;

EID: 34548569313     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06753.x     Document Type: Letter

References (10)

1. Anolik, J.H., Blumberg, N., Snider, J. Francis, C.W. (2001) Posttransfusion purpura secondary to an alloantibody reactive with HPA-5a [Br(b)]. Transfusion, 41, 633 636.
2. Bertrand, G., Jallu, V., Gouet, M., Kjaer, K.M., Lambin, P., Husebekk, A. Kaplan, C. (2005) Quantification of human platelet antigen-1a antibodies with the monoclonal antibody immobilization of platelet antigens procedure. Transfusion, 45, 1319 1323.
3. Bertrand, G., Martageix, C., Jallu, V., Vitry, F. Kaplan, C. (2006) Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia. Journal of Thrombosis and Haemostasis, 4, 628 637.
4. Davoren, A., Curtis, B.R., Aster, R.H. McFarland, J.G. (2004) Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion, 44, 1220 1225.
5. Kiefel, V., Konig, C., Kroll, H. Santoso, S. (2001) Platelet alloantibodies in transfused patients. Transfusion, 41, 766 770.
6. Mueller-Eckhardt, C., Kiefel, V., Grubert, A., Kroll, H., Weisheit, M., Schmidt, S., Mueller-Eckhardt, G. Santoso, S. (1989) 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet, 1, 363 366.
7. Osterwalder, B., Gratwohl, A., Nissen, C. Speck, B. (1986) Immunoadsorption for removal of anti-A and anti-B blood group antibodies in ABO-incompatible bone marrow transplantation. Blut, 53, 379 390.
8. Santoso, S., Kalb, R., Walka, M., Kiefel, V., Mueller-Eckhardt, C. Newman, P.J. (1993) The human platelet alloantigens Br(a) and Brb are associated with a single amino acid polymorphism on glycoprotein Ia (integrin subunit alpha 2). Journal of Clinical Investigation, 92, 2427 2432.
9. Stussi, G., Halter, J., Schanz, U. Seebach, J.D. (2006) ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation. Transfusion and Apheresis Science, 35, 59 69.
10. Valeri, C.R. Ragno, G. (2006) Cryopreservation of human blood products. Transfusion and Apheresis Science, 34, 271 287.